HI-FIVE试验:使用四维68镓通气-灌注正电子发射断层扫描-计算机断层扫描在局部晚期非小细胞肺癌中实现功能性肺回避的前瞻性试验
该前瞻性试验纳入III期非小细胞肺癌患者,使用四维68镓通气-灌注PET/CT生成功能肺体积并制定功能性肺回避(FLA)放疗计划至60 Gy/30次、原发肿瘤推量至69 Gy。18例接受FLA放化疗的患者中15例达到可行性标准,功能平均肺剂量平均降低12.4%,fV20Gy平均相对降低22.9%,12个月总生存率83%。结论认为使用该技术成像并回避功能肺是可行的。
要点
- 18例接受FLA放化疗患者中15例达到可行性标准。
- FLA使功能平均肺剂量平均降低12.4%(SD ±12.8%),fV20Gy平均相对降低22.9%(SD ±11.9%)。
- 12个月总生存率83%(95% CI 56%-94%),无进展生存率50%(95% CI 26%-70%)。
核心结论
- 使用68Ga-4D-V/Q PET/CT成像并回避功能肺是可行的。
研究设计与样本
- 前瞻性试验纳入III期非小细胞肺癌且能接受根治性放化疗的患者,计划放疗至60 Gy/30次、原发肿瘤推量至69 Gy,并为每例患者生成解剖计划作为对比。
主要发现
- 共招募19例患者,1例撤回知情同意,18例接受FLA放化疗,其中15例达到可行性标准。
- 全部患者完成整个放化疗疗程。
- 使用FLA导致功能平均肺剂量平均降低12.4%(SD ±12.8%),fV20Gy平均相对降低22.9%(SD ±11.9%)。
- 12个月时Kaplan-Meier估计的总生存率为83%(95% CI 56%-94%),无进展生存率为50%(95% CI 26%-70%)。
- 生活质量评分在所有时间点保持稳定。
关键数值与推荐
- 可行性标准为:FLA计划较解剖计划使功能平均肺剂量降低≥2%且fV20Gy降低≥4%,同时平均心脏剂量≤30 Gy且相对心脏体积接受50 Gy<25%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Functional lung avoidance (FLA) radiation therapy aims to spare regions of functional lung to reduce toxicity. We report the results of the first prospective trial of FLA using 4-dimensional gallium 68 ventilation-perfusion positron emission tomography-computed tomography (68Ga-4D-V/Q PET/CT). METHODS AND MATERIALS: Inclusion criteria required a diagnosis of stage III non-small cell lung cancer and the ability to undergo radical-intent chemoradiation therapy. Functional volumes were generated using planning 68Ga-4D-V/Q PET/CT. These volumes were used to generate a clinical FLA plan to 60 Gy in 30 fractions. The primary tumor was boosted to 69 Gy. A comparison anatomic plan was generated for each patient. Feasibility was met if FLA plans (compared with anatomic plans) allowed (1) a reduction in functional mean lung dose of ≥2% and a reduction in the functional lung volume receiving 20 Gy (fV20Gy) of ≥4%, and (2) a mean heart dose ≤30 Gy and relative heart volume receiving 50 Gy of <25%. RESULTS: In total, 19 patients were recruited; 1 withdrew consent. Eighteen patients underwent chemoradiation with FLA. Of the 18 patients, 15 met criteria for feasibility. All patients completed the entire course of chemoradiation therapy. Using FLA resulted in an average reduction of the functional mean lung dose of 12.4% (SD, ±12.8%) and a mean relative reduction of the fV20Gy of 22.9% (SD, ±11.9%). At 12 months, Kaplan-Meier estimates for overall survival were 83% (95% CI, 56%-94%) and estimates for progression-free survival were 50% (95% CI, 26%-70%). Quality-of-life scores were stable across all time points. CONCLUSIONS: Using 68Ga-4D-V/Q PET/CT to image and avoid functional lung is feasible.
引用
- Bucknell NW, Hardcastle N, Woon B, et al. The HI-FIVE Trial: A Prospective Trial Using 4-Dimensional 68Ga Ventilation-Perfusion Positron Emission Tomography-Computed Tomography for Functional Lung Avoidance in Locally Advanced Non-small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2023. PMID: 37245537. doi:10.1016/j.ijrobp.2023.05.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。